Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum .

Schistosomiasis is one of the world's major public health problems. Praziquantel is currently the only effective drug against schistosomiasis. As resistance of praziquantel has emerged in some endemic areas, development of new antischistosomal agents should be a high priority. In this study, a phage display peptide library was used for screening for peptide antagonists of thioredoxin glutathione reductase of Schistosoma japonicum (SjTGR), which has been identified as an alternative drug target. Three rounds of panning produced four different fusion phages. ELISA proved that all four phages could bind to SjTGR. One peptide, JIPDysl (aa, WPHNWWPHFKVK), reduced enzyme activity of SjTGR by more than 50%. 2 tiM of the synthesized peptide of JIPDysl inhibited the activity of TrxR, GR, and Grx of SjTGR by 32.5%, 100%, and 100%, respectively. The IC50 values of the synthetic peptide JIPDysl for TrxR, GR, and Grx were 3.67 mu M, 0.11 mu M, and 0.97 mu M, respectively. Based on computer simulation, it appeared that JIPDysl binds to the substrate binding sites of glutathione reductase (GR) and glutaredoxin (Grx). Our data show that the peptide, JIPDysl (aa, WPHNWWPHFKVK), is a promising candidate to develop novel drugs against S. japonicum which acts by binding with SjTGR and reduces enzyme activity of SjTGR.